Clearstead Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$77K Buy
173
+9
+5% +$4.01K 0.01% 271
2025
Q1
$79.5K Sell
164
-70
-30% -$33.9K 0.02% 229
2024
Q4
$94.2K Buy
234
+97
+71% +$39.1K 0.02% 210
2024
Q3
$63.7K Hold
137
0.02% 222
2024
Q2
$64.2K Hold
137
0.02% 219
2024
Q1
$57.3K Buy
137
+70
+104% +$29.3K 0.02% 232
2023
Q4
$27.3K Sell
67
-30
-31% -$12.2K 0.01% 272
2023
Q3
$33.7K Buy
97
+30
+45% +$10.4K 0.01% 247
2023
Q2
$21.1K Hold
67
0.01% 268
2023
Q1
$21.1K Hold
67
0.01% 262
2022
Q4
$19K Hold
67
0.01% 284
2022
Q3
$19K Hold
67
0.01% 261
2022
Q2
$19K Hold
67
0.01% 137
2022
Q1
$17K Buy
+67
New +$17K 0.01% 145
2021
Q4
Sell
-10,459
Closed -$1.9M 197
2021
Q3
$1.9M Sell
10,459
-294
-3% -$53.3K 1.2% 25
2021
Q2
$2.34M Sell
10,753
-735
-6% -$160K 1.53% 23
2021
Q1
$2.47M Buy
11,488
+554
+5% +$119K 1.83% 20
2020
Q4
$2.58M Buy
+10,934
New +$2.58M 1.54% 23
2017
Q3
Sell
-375
Closed -$48K 235
2017
Q2
$48K Buy
+375
New +$48K 0.04% 160